Medicine
Pantoprazole 40 mg powder for injection
Pantoprazole 40 mg powder for injection is a generic prescription medicine for intravenous use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Pantoprazole
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 10 vials, 25 vials, 5 vials and 6 more
- Manufacturers
- Camber PharmaceuticalsIndiaEugiaIndiaCardinal HealthHikma PharmaceuticalsCivica
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A02BC02 Pantoprazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 March 2016
- Identifiers
- RxCUI 283669DailyMed set ID 1e102c44-232b-4aaf-b457-2a740c47193a, 362229c5-7b28-4563-aa62-d97d06005480, 1bb94d3c-8bc3-4193-9dd8-e9a22066707c +4NDC 0143-9300, 55154-7477, 31722-204 +4Application NDA209463, ANDA213778, ANDA205675
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 31722-204-10 | Camber PharmaceuticalsIndia | 18 May 2022 |
| 25 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 31722-204-32 | Camber PharmaceuticalsIndia | 18 May 2022 |
| 10 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 55150-202-10 | EugiaIndia | 30 March 2016 |
| 25 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 55150-202-25 | EugiaIndia | 30 March 2016 |
| 10 vial in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial | 0143-9284-10 | Hikma Pharmaceuticals | 22 September 2017 |
| 10 vial in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial | 0143-9300-10 | Hikma Pharmaceuticals | 22 September 2017 |
| 5 vial in 1 bag / 1 injection, powder, lyophilized, for solution in 1 vial | 55154-7477-5 | Cardinal Health | 22 September 2017 |
| 5 vial, single-dose in 1 bag / 1 injection, powder, for solution in 1 vial, single-dose | 55154-8336-5 | Cardinal Health | 30 March 2016 |
| 10 vial in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial | 72572-553-10 | Civica | 1 June 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Pantoprazole
Clinical summary
Pantoprazole is a proton pump inhibitor indicated for pROTONIX is a proton pump inhibitor (PPI) indicated for the following, among other approved uses. MedsAcross supplies Pantoprazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PantoprazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Protonix Delayed-Release prescribing information (Wyeth Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Controloc Control: European public assessment report (EPAR) · European Medicines Agency
- Pantozol Control: European public assessment report (EPAR) · European Medicines Agency
Need Pantoprazole 40 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.